BioLineRx Ltd. — Form D
BioLineRx Ltd. of MODI'IN, L3, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-10. The offering totals $4.4M, of which $4.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-06-10
- Form: D
- Accession: 0001178913-20-001769
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $4.4M
- Amount sold: $4.4M
- Investors: 5
- Date of first sale: 2020-05-31
- Revenue range: Decline to Disclose
- SEC file number: 021-368607
Issuer
- Name: BioLineRx Ltd.
- CIK: 0001498403
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Address: 2 HAMA'AYAN STREET, MODI'IN, L3, 7177871
- Phone: 972-8-642-9100
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Barbara Jean Bormann | Director | Modi'in, L3 |
| Mali A Zeevi | Executive Officer | Modi'in, L3 |
| Raphael Jean Hofstein | Director | Modi'in, L3 |
| Avraham Jean Molcho | Director | Modi'in, L3 |
| Philip A Serlin | Executive Officer | Modi'in, L3 |
| Aharon Schwartz | Director | Modi'in, L3 |
| Nurit J Benjamini | Director | Modi'in, L3 |
| Abi A Vainstein-Haras | Executive Officer | Modi'in, L3 |
| Michael J Anghel | Director | Modi'in, L3 |
| Sandra Jean Panem | Director | Modi'in, L3 |
| Ella A Sorani | Executive Officer | Modi'in, L3 |
Other filings by this issuer (1)
More